article Open AccessTop 1% cited
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2014 · Vol. 25 · pp. iii49–iii56
Bernard Escudier✉(Institut Gustave Roussy)Camillo Porta(University of Pavia)Manuela Schmidinger(Comprehensive Cancer Center Vienna)Ferrán Algaba(Universitat Autònoma de Barcelona)Jean Jacques Patard(Université Paris-Saclay)Vincent Khoo(Institute of Cancer Research)Timothy Eisen(University of Pavia)Alan Horwich(Institute of Cancer Research)
Renal cell carcinoma treatmentRenal and related cancersGenetic and Kidney Cyst DiseasesMedicineRenal cell carcinomaTuberous sclerosisInternal medicineCancerBAP1PopulationDiseaseClear cell renal cell carcinomaOncology
MeSH terms
Carcinoma, Renal CellCombined Modality TherapyFollow-Up StudiesHealth Planning GuidelinesHumansKidney NeoplasmsNeoplasm StagingPrognosisSocieties, Medical
Citations
2,255
FWCI
111.54
field-weighted impact
References
108
Percentile
100%
vs. same field & year
Citations per year
Cited by
Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy
Cancers · 2020 · 498 citations
International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
European Urology · 2014 · 1,009 citations
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Journal of Hepatology · 2021 · 3,953 citations
References
Sorafenib in Advanced Hepatocellular Carcinoma
New England Journal of Medicine · 2008 · 12,835 citations
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
Hepatology · 2003 · 3,004 citations
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
The American Journal of Surgical Pathology · 2013 · 842 citations
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
The Lancet Oncology · 2008 · 5,801 citations
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
European Journal of Cancer · 2011 · 570 citations
Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma
Gastroenterology · 2002 · 1,434 citations
Prognostic significance of morphologic parameters in renal cell carcinoma
The American Journal of Surgical Pathology · 1982 · 2,738 citations
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
Hepatology · 2002 · 2,609 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.